This study was undertaken to investigate the synergistic interaction between amphotericin B (AmB) and acteoside, isolated from the aerial parts of the shrub Colebrookea oppositifolia (Lamiaceae). Acteoside alone exhibited no intrinsic antifungal activity but showed a potent synergism in combination with AmB against selected pathogenic species, with fractional inhibitory concentration indices in the range of 0.0312–0.1562. The combination of acteoside at 3.12 and 12.5 µg ml–1 with subinhibitory concentrations of AmB resulted in a potent fungicidal effect and also exhibited a significantly extended post-antifungal effect. Furthermore, the combination also reduced the minimum biofilm reduction concentration values of AmB (2–16-fold) in preformed biofilms of Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus. There was decreased viability of the cells, increased uptake of propidium iodide and enhanced leakage of 260 nm-absorbing material by Candida albicans cells when exposed to AmB in the presence of acteoside. The reason for potentiation is likely to be that the subinhibitory concentrations of AmB facilitated the uptake of acteoside, which resulted in increased killing of the fungal cells. Administration of acteoside in mice at up to 2000 mg (kg body weight)−1 by the intraperitoneal or oral route produced no overt toxicity. The data presented here support synergism between acteoside and AmB, and it is therefore proposed that a prospective new management strategy for therapeutic application of this combination should be explored.
AndrewsF. A.,
BeggsW. H.,
SarosiG. A.1977; Influence of antioxidants on the bioactivity of amphotericin B. Antimicrob Agents Chemother 11:615–618[PubMed][CrossRef]
BeggsW. H.,
AndrewsF. A.,
SarosiG. A.1978; Synergistic action of amphotericin B and antioxidants against certain opportunistic yeast pathogens. Antimicrob Agents Chemother 13:266–270[PubMed][CrossRef]
CLSI2008aReference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts Approved standard M27–A3 Wayne, PA: Clinical and Laboratory Standards Institute;
CoxS. D.,
MannC. M.,
MarkhamJ. L.,
GustafsonJ. E.,
WarmingtonJ. R.,
WyllieS. G.2001; Determining the antimicrobial actions of tea tree oil. Molecules 6:87–91 [View Article]
CraigW. A.,
GudmundssonS.1996; Postantibiotic effect. In Antibiotics in Laboratory Medicine, 4th edn. pp. 296–329 Edited by
LorianV.
Baltimore, MD: Williams and Wilkins Co;
CSIR1956The Wealth of India: a Dictionary of Indian Raw Materials and Industrial Productsvol. 2 New Delhi: Council of Scientific and Industrial Research;
DíazA. M.,
AbadM. J.,
FernándezL.,
SilvánA. M.,
De SantosJ.,
BermejoP.2004; Phenylpropanoid glycosides from Scrophularia scorodonia: in vitro anti-inflammatory activity. Life Sci 74:2515–2526 [View Article][PubMed]
EliopoulusG. M.,
MoelleringR. C. J.1996; Antimicrobial combinations. In Antibiotics in Laboratory Medicine, 4th edn. pp. 330–396 Edited by
LorianV.
Baltimore, MD: Williams and Wilkins Co;
FerreiraJ. A. G.,
CarrJ. H.,
StarlingC. E. F.,
de ResendeM. A.,
DonlanR. M.2009; Biofilm formation and effect of caspofungin on biofilm structure of Candida species bloodstream isolates. Antimicrob Agents Chemother 53:4377–4384 [View Article][PubMed]
HemaiswaryaS.,
KruthiventiA. K.,
DobleM.2008; Synergism between natural products and antibiotics against infectious diseases. Phytomedicine 15:639–652 [View Article][PubMed]
JoungY. H.,
KimH. R.,
LeeM. K.,
ParkA. J.2007; Fluconazole susceptibility testing of Candida species by flow cytometry. J Infect 54:504–508 [View Article][PubMed]
KhanI. A.,
MirzaZ. M.,
KumarA.,
VermaV.,
QaziG. N.2006; Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus
. Antimicrob Agents Chemother 50:810–812[CrossRef]
KumarA.,
KhanI. A.,
KoulS.,
KoulJ. L.,
TanejaS. C.,
AliI.,
AliF.,
SharmaS.,
MirzaZ. M. et al.2008; Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus
. J Antimicrob Chemother 61:1270–1276[CrossRef]
MarchettiO.,
MoreillonP.,
GlauserM. P.,
BilleJ.,
SanglardD.2000; Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans
. Antimicrob Agents Chemother 44:2373–2381 [View Article][PubMed]
MarinéM.,
EspadaR.,
TorradoJ.,
PastorF. J.,
GuarroJ.2008; Efficacy of a new formulation of amphotericin B in a murine model of disseminated infection by Candida glabrata
. J Antimicrob Chemother 61:880–883 [View Article][PubMed]
MarrK. A.,
BoeckhM.,
CarterR. A.,
KimH. W.,
CoreyL.2004; Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis 39:797–802 [View Article][PubMed]
MartinezL. R.,
CasadevallA.2006; Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro
. Antimicrob Agents Chemother 50:1021–1033 [View Article][PubMed]
MowatE.,
ButcherJ.,
LangS.,
WilliamsC.,
RamageG.2007; Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus
. J Med Microbiol 56:1205–1212 [View Article][PubMed]
Ostrosky-ZeichnerL.,
MarrK. A.,
RexJ. H.,
CohenS. H.2003; Amphotericin B: time for a new “gold standard”. Clin Infect Dis 37:415–425 [View Article][PubMed]
PfallerM. A.,
SheehanD. J.,
RexJ. H.2004; Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardization. Clin Microbiol Rev 17:268–280 [View Article][PubMed]
PierceC. G.,
UppuluriP.,
TristanA. R.,
WormleyF. L.Jr,
MowatE.,
RamageG.,
Lopez-RibotJ. L.2008; A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc 3:1494–1500 [View Article][PubMed]
QaziG. N.,
SuriO. P.,
BediK. L.,
SuriK. A.,
GuptaB. D.,
JaggiB. S.,
KapahiB. K.,
SattiN. K.,
AminaM.other authors2006; Hepatoprotective agent of plant origin and a process thereof United States Patent number US 6,989,162 B2.
RamageG.,
Vande WalleK.,
WickesB. L.,
López-RibotJ. L.2001; Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 45:2475–2479 [View Article][PubMed]
SaxenaA.,
SaxenaA. K.,
SinghJ.,
BhushanS.2010; Natural antioxidants synergistically enhance the anticancer potential of AP9-cd, a novel lignan composition from Cedrus deodara in human leukemia HL-60 cells. Chem Biol Interact 188:580–590 [View Article][PubMed]
ShufordJ. A.,
PiperK. E.,
SteckelbergJ. M.,
PatelR.2007; In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates. Diagn Microbiol Infect Dis 57:277–281 [View Article][PubMed]
WilsonL. S.,
ReyesC. M.,
StolpmanM.,
SpeckmanJ.,
AllenK.,
BeneyJ.2002; The direct cost and incidence of systemic fungal infections. Value Health 5:26–34 [View Article][PubMed]
WuY.-T.,
LinL.-C.,
SungJ.-S.,
TsaiT.-H.2006; Determination of acteoside in Cistanche deserticola and Boschniakia rossica and its pharmacokinetics in freely-moving rats using LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 844:89–95 [View Article][PubMed]
WuY.-T.,
TsaiT.-R.,
LinL.-C.,
TsaiT.-H.2007; Liquid chromatographic method with amperometric detection to determine acteoside in rat blood and brain microdialysates and its application to pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 853:281–286 [View Article][PubMed]
ZhangL.,
YanK.,
ZhangY.,
HuangR.,
BianJ.,
ZhengC.,
SunH.,
ChenZ.,
SunN. et al.2007; High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections. Proc Natl Acad Sci U S A 104:4606–4611 [View Article][PubMed]